ArticleFrontiers in genetics2021

Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers.

Mengjing Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.